These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 28722341)
1. Proteomic Analysis of Neuroblastoma-Derived Exosomes: New Insights into a Metastatic Signature. Colletti M; Petretto A; Galardi A; Di Paolo V; Tomao L; Lavarello C; Inglese E; Bruschi M; Lopez AA; Pascucci L; Geoerger B; Peinado H; Locatelli F; Di Giannatale A Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28722341 [TBL] [Abstract][Full Text] [Related]
2. Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. Marimpietri D; Petretto A; Raffaghello L; Pezzolo A; Gagliani C; Tacchetti C; Mauri P; Melioli G; Pistoia V PLoS One; 2013; 8(9):e75054. PubMed ID: 24069378 [TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Exosomes Secreted by Breast Cancer Cells with Varying Metastatic Potential. Gangoda L; Liem M; Ang CS; Keerthikumar S; Adda CG; Parker BS; Mathivanan S Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 29115712 [TBL] [Abstract][Full Text] [Related]
5. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma. Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292 [TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis identifies exosomal Eps8 protein as a potential metastatic biomarker for pancreatic cancer. Ohshima K; Hatakeyama K; Kanto K; Ide T; Watanabe Y; Moromizato S; Wakabayashi-Nakao K; Sakura N; Yamaguchi K; Mochizuki T Oncol Rep; 2019 Feb; 41(2):1019-1034. PubMed ID: 30431134 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow. Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764 [TBL] [Abstract][Full Text] [Related]
8. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Lazar I; Clement E; Ducoux-Petit M; Denat L; Soldan V; Dauvillier S; Balor S; Burlet-Schiltz O; Larue L; Muller C; Nieto L Pigment Cell Melanoma Res; 2015 Jul; 28(4):464-75. PubMed ID: 25950383 [TBL] [Abstract][Full Text] [Related]
10. NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells. Shoae-Hassani A; Hamidieh AA; Behfar M; Mohseni R; Mortazavi-Tabatabaei SA; Asgharzadeh S J Immunother; 2017 Sep; 40(7):265-276. PubMed ID: 28622272 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of bone marrow as a metastatic site of human neuroblastoma. Morandi F; Corrias MV; Pistoia V Ann N Y Acad Sci; 2015 Jan; 1335():23-31. PubMed ID: 25315505 [TBL] [Abstract][Full Text] [Related]
12. Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules. Boussadia Z; Lamberti J; Mattei F; Pizzi E; Puglisi R; Zanetti C; Pasquini L; Fratini F; Fantozzi L; Felicetti F; Fecchi K; Raggi C; Sanchez M; D'Atri S; Carè A; Sargiacomo M; Parolini I J Exp Clin Cancer Res; 2018 Oct; 37(1):245. PubMed ID: 30290833 [TBL] [Abstract][Full Text] [Related]
13. Differential RNA Expression Between Metastatic and Primary Neuroblastoma Cells. Lee WG; Asuelime GE; Asuelime-Smith MBT; Chen SY; Kim ES J Surg Res; 2024 Jun; 298():240-250. PubMed ID: 38631173 [TBL] [Abstract][Full Text] [Related]
14. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma. Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study. Osman J; Galli S; Hanafy M; Tang X; Ahmed A Clin Transl Oncol; 2013 Nov; 15(11):953-8. PubMed ID: 23553333 [TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression. Rifatbegovic F; Frech C; Abbasi MR; Taschner-Mandl S; Weiss T; Schmidt WM; Schmidt I; Ladenstein R; Ambros IM; Ambros PF Int J Cancer; 2018 Jan; 142(2):297-307. PubMed ID: 28921546 [TBL] [Abstract][Full Text] [Related]
17. HFE genotype affects exosome phenotype in cancer. Mrowczynski OD; Madhankumar AB; Slagle-Webb B; Lee SY; Zacharia BE; Connor JR Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1921-1928. PubMed ID: 28527894 [TBL] [Abstract][Full Text] [Related]
18. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes. Vardaki I; Ceder S; Rutishauser D; Baltatzis G; Foukakis T; Panaretakis T Oncotarget; 2016 Nov; 7(46):74966-74978. PubMed ID: 27589561 [TBL] [Abstract][Full Text] [Related]
19. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. Russell HV; Hicks J; Okcu MF; Nuchtern JG J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. He M; Qin H; Poon TC; Sze SC; Ding X; Co NN; Ngai SM; Chan TF; Wong N Carcinogenesis; 2015 Sep; 36(9):1008-18. PubMed ID: 26054723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]